Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2026-02-20 @ 8:25 PM
Study NCT ID:
NCT02991859
Status:
COMPLETED
Last Update Posted:
2020-07-31
First Post:
2016-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-09
First Submit QC Date:
None
Study First Post Date:
2016-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-19
Results First Submit QC Date:
None
Results First Post Date:
2020-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-14
Last Update Post Date:
2020-07-31
Last Update Post Date Type:
ACTUAL